« Walk for Life

Cancer vaccines targeting breast and ovarian »

Zacks Analyst Blog Highlights: Vivus, Roche, Glaxo Smith Kline, Abbott and Therapeutics orexigenic

Zacks Analyst Blog Highlights: Vivus, Roche, GlaxoSmithKline, Abbott and Orexigen Therapeutics
Zacks Analyst Blog Highlights: Vivus, Roche, GlaxoSmithKline, Abbott and Orexigen Therapeutics

Read more on Zacks.com via Yahoo! Finance

This entry was posted by admin on July 15, 2010 at 8:24 am, and is filed under Health Conditions. Follow any responses to this post through RSS 2.0.You can leave a response or trackback from your own site.

Comments (0)
Related Posts

Comment Feed for this Post

Go to Top